Headline
The latest stories from AHA Today.
AHA yesterday urged the Centers for Medicare & Medicaid Services to adjust its proposed fiscal year 2024 market basket update for inpatient psychiatric facilities to account for underpayments in FY 2022 relative to inflation.
A new AHA infographic shows how legislation that would impose billions of dollars in additional site-neutral payment reductions to services provided in off-campus hospital outpatient departments (HOPDs) fails to account for the fundamental differences between HOPDs and other ambulatory care sites,…
More than 200 hospital and health system leaders on June 6 participated in an AHA Advocacy Day briefing to get the latest developments from Capitol Hill. AHA leaders briefed those in attendance on a number of issues, including site-neutral payment policies, the 340B Drug Pricing Program,…
A University of Michigan expert discusses how environmental sustainability efforts can benefit hospitals and health systems and supplement their other ongoing initiatives like engaging the workforce.
Hospitals and health systems committed to leadership and innovation in improving quality and advancing health are invited to apply for the 2024 AHA Quest for Quality Prize
Health and Human Services Secretary Xavier Becerra June 2 declared a public health emergency in the territory of Guam due to Typhoon Mawar, and waived or modified certain Medicare, Medicaid and Children’s Health Insurance Program requirements to ensure sufficient health care items and services are…
In comments submitted June 5, AHA said it appreciates that the Centers for Medicare & Medicaid Services proposed a net positive update for the skilled nursing facility prospective payment system for fiscal year 2024, but remains concerned that the agency’s market basket approach lags in…
In comments submitted June 5, AHA said it appreciates that the Centers for Medicare & Medicaid Services has not proposed any major payment or coverage changes to the Inpatient Rehabilitation Facility Prospective Payment System for fiscal year 2024, but urged the agency to consider changing its…
The FDA on June 2 told AHA that is has worked with Qilu Pharmaceuticals and Apotex Corp. to temporarily import cisplatin, a drug used in chemotherapy, after a national shortage.
The application window for AHA’s 2024 Circle of Life Awards is now open. The award recognizes programs and organizations that provide innovative palliative or end-of-life care. The deadline to apply is July 10.